Authors:
Mollereau, C
Gouarderes, C
Dumont, Y
Kotani, M
Detheux, M
Doods, H
Parmentier, M
Quirion, R
Zajac, JM
Citation: C. Mollereau et al., Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226, BR J PHARM, 133(1), 2001, pp. 1-4
Citation: Dm. Wu et al., Effects of BIIB513 on ischemia-induced arrhythmias and myocardial infarction in anesthetized rats, BAS R CARD, 95(6), 2000, pp. 449-456
Authors:
King, PJ
Widdowson, PS
Doods, H
Williams, G
Citation: Pj. King et al., Regulation of neuropeptide Y release from hypothalamic slices by melanocortin-4 agonists and leptin, PEPTIDES, 21(1), 2000, pp. 45-48
Authors:
Wu, DM
Eberlein, W
Rudolf, K
Engel, W
Hallermayer, G
Doods, H
Citation: Dm. Wu et al., Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2,7)]hCGRP-preferring receptor, EUR J PHARM, 400(2-3), 2000, pp. 313-319
Authors:
King, PJ
Williams, G
Doods, H
Widdowson, PS
Citation: Pj. King et al., Effect of a selective neuropeptide YY2 receptor antagonist, BIIE0246 on neuropeptide Y release, EUR J PHARM, 396(1), 2000, pp. R1-R3
Authors:
Dumont, Y
Cadieux, A
Doods, H
Fournier, A
Quirion, R
Citation: Y. Dumont et al., Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIBO3304 (Y1) and CGP71683A (Y5), CAN J PHYSL, 78(2), 2000, pp. 116-125
Authors:
Powell, KJ
Ma, WY
Sutak, M
Doods, H
Quirion, R
Jhamandas, K
Citation: Kj. Powell et al., Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists, BR J PHARM, 131(5), 2000, pp. 875-884
Authors:
Dumont, Y
Cadieux, A
Doods, H
Pheng, LH
Abounader, R
Hamel, E
Jacques, D
Regoli, D
Quirion, R
Citation: Y. Dumont et al., BIIE0246, a potent and highly selective non-peptide neuropeptide YY2 receptor antagonist, BR J PHARM, 129(6), 2000, pp. 1075-1088
Authors:
Doods, H
Hallermayer, G
Wu, DM
Entzeroth, M
Rudolf, K
Engel, W
Eberlein, W
Citation: H. Doods et al., Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist, BR J PHARM, 129(3), 2000, pp. 420-423